IDUA encodes alpha-L-iduronidase, a lysosomal exo-glycosidase (glycosyl hydrolase family 39; EC 3.2.1.76) that hydrolyses terminal, non-reducing alpha-L-iduronic acid residues from the glycosaminoglycans heparan sulfate and dermatan sulfate. It is one of the sequential enzymes of lysosomal glycosaminoglycan catabolism, acting by a retaining double-displacement mechanism (nucleophile Glu299, general acid/base Glu182); an N-glycan attached to Asn372 forms part of the substrate-binding pocket and is required for full activity. The enzyme is a monomer that is trafficked to and acts within the lysosomal lumen. Loss of IDUA activity blocks GAG degradation and causes lysosomal accumulation and urinary excretion of heparan sulfate and dermatan sulfate, producing mucopolysaccharidosis type I, which spans a clinical spectrum from severe (Hurler syndrome) through intermediate (Hurler-Scheie) to attenuated (Scheie syndrome).
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0003940 L-iduronidase activity | IBA GO_REF:0000033 | ACCEPT | Summary: Phylogenetic (IBA) assignment of the defining catalytic activity of IDUA, L-iduronidase activity. This is the core molecular function of the gene and is concordant with direct experimental structural/biochemical evidence. Reason: L-iduronidase activity is the well-established core function of IDUA, confirmed by crystal structures and enzyme kinetics of the human enzyme. The IBA call is consistent with the manual experimental annotations. Supporting Evidence: PMID:24036510 IDUA participates in the stepwise degradation of the glycosaminoglycans (GAGs) heparan sulphate and dermatan sulphate, by removing a single Ξ±-L-iduronyl residue from the non-reducing ends of these complex polysaccharides. file:human/IDUA/IDUA-uniprot.txt RecName: Full=Alpha-L-iduronidase; |
| GO:0003940 L-iduronidase activity | IEA GO_REF:0000120 | ACCEPT | Summary: Electronic (multi-method IEA) assignment of L-iduronidase activity, mapped in part from EC 3.2.1.76. Correct and identical to the experimentally supported core molecular function. Reason: Redundant with the experimentally supported GO:0003940 annotations; the EC 3.2.1.76 mapping is exactly the enzyme's activity. Supporting Evidence: file:human/IDUA/IDUA-uniprot.txt EC=3.2.1.76; |
| GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compounds | IEA GO_REF:0000002 | KEEP AS NON CORE | Summary: InterPro-derived (IPR000514, Glyco_hydro_39) mapping to the general parent term for O-glycosyl hydrolases. Correct but less informative than the specific L-iduronidase activity term. Reason: IDUA is a glycoside hydrolase family 39 member and does hydrolyse O-glycosyl (alpha-L-iduronosidic) linkages, so the term is not wrong, but it is a broad grouping term subsumed by the specific GO:0003940 L-iduronidase activity. Kept as non-core rather than treated as the representative molecular function. Supporting Evidence: file:human/IDUA/IDUA-uniprot.txt Belongs to the glycosyl hydrolase 39 family. |
| GO:0005764 lysosome | IEA GO_REF:0000044 | ACCEPT | Summary: UniProt Subcellular-Location keyword mapping placing IDUA in the lysosome. This is the correct and physiologically relevant compartment for the enzyme. Reason: IDUA is a mannose-6-phosphate-targeted lysosomal hydrolase; lysosomal localization is central to its function and is asserted by UniProt with literature support. Supporting Evidence: file:human/IDUA/IDUA-uniprot.txt SUBCELLULAR LOCATION: Lysosome |
| GO:0005975 carbohydrate metabolic process | IEA GO_REF:0000002 | KEEP AS NON CORE | Summary: InterPro-derived high-level biological-process term. IDUA does participate in carbohydrate metabolism, but this is a very broad grouping term subsumed by the specific glycosaminoglycan catabolic annotations. Reason: Not incorrect, but far too general; the informative processes are heparan sulfate and dermatan sulfate catabolism. Retained as non-core. Supporting Evidence: PMID:24036510 IDUA participates in the stepwise degradation of the glycosaminoglycans (GAGs) heparan sulphate and dermatan sulphate, by removing a single Ξ±-L-iduronyl residue from the non-reducing ends of these complex polysaccharides. |
| GO:0030200 heparan sulfate proteoglycan catabolic process | IEA GO_REF:0000117 | ACCEPT | Summary: ARBA electronic assignment of heparan sulfate proteoglycan catabolism, one of the two core degradative pathways in which IDUA acts. Well supported by experimental and structural evidence. Reason: IDUA removes terminal alpha-L-iduronate from heparan sulfate during its stepwise lysosomal degradation; loss of IDUA blocks HS breakdown (HS accumulation in Idua-deficient mice). Supporting Evidence: PMID:24036510 IDUA participates in the stepwise degradation of the glycosaminoglycans (GAGs) heparan sulphate and dermatan sulphate, by removing a single Ξ±-L-iduronyl residue from the non-reducing ends of these complex polysaccharides. PMID:21873421 representing the terminal iduronic acid residue capping the non-reducing end of the HS chain, where no further degradation can occur in the absence of Idua. |
| GO:0030209 dermatan sulfate proteoglycan catabolic process | IEA GO_REF:0000117 | ACCEPT | Summary: ARBA electronic assignment of dermatan sulfate proteoglycan catabolism, the second core degradative pathway of IDUA. Duplicated by an experimental IDA annotation below. Reason: IDUA hydrolyses the unsulfated alpha-L-iduronosidic linkages of dermatan sulfate (this is its defining EC 3.2.1.76 reaction); a core biological process. Supporting Evidence: file:human/IDUA/IDUA-uniprot.txt Hydrolysis of unsulfated alpha-L-iduronosidic linkages in PMID:24036510 IDUA participates in the stepwise degradation of the glycosaminoglycans (GAGs) heparan sulphate and dermatan sulphate, by removing a single Ξ±-L-iduronyl residue from the non-reducing ends of these complex polysaccharides. |
| GO:0030211 heparin proteoglycan catabolic process | IEA GO_REF:0000117 | ACCEPT | Summary: ARBA electronic assignment of heparin proteoglycan catabolism. Heparin is a highly sulfated relative of heparan sulfate bearing the same alpha-L-iduronosidic linkages, on which IDUA acts. Supported experimentally by the Idua-knockout mouse (below) and retained consistent with that IMP. Reason: Heparin shares the alpha-L-iduronosidic linkages of heparan sulfate, and the Idua-deficient mouse demonstrates that terminal iduronate removal from these chains requires IDUA. Kept consistent with the IMP annotation to the same term. Supporting Evidence: PMID:21873421 representing the terminal iduronic acid residue capping the non-reducing end of the HS chain, where no further degradation can occur in the absence of Idua. |
| GO:0043202 lysosomal lumen | IEA GO_REF:0000117 | ACCEPT | Summary: ARBA electronic assignment of lysosomal lumen localization. This is the precise compartment in which IDUA carries out GAG degradation and is well supported. Reason: IDUA is a soluble lysosomal hydrolase acting in the acidic lumen; the more specific lumen term is preferable to the generic lysosome term and is retained as a core localization. Supporting Evidence: file:human/IDUA/IDUA-uniprot.txt SUBCELLULAR LOCATION: Lysosome |
| GO:0005102 signaling receptor binding | IEA GO_REF:0000107 | MARK AS OVER ANNOTATED | Summary: Electronic annotation transferred from the rat ortholog (D3ZE16) via Ensembl Compara. There is no evidence that IDUA, a soluble lysosomal glycosidase, acts as a signaling receptor ligand. Reason: IDUA is a lysosomal hydrolase with no established signaling-ligand role; this is an uninformative binding term propagated electronically from an ortholog and is not supported by the human literature or structural/functional characterization. Supporting Evidence: file:human/IDUA/IDUA-uniprot.txt Lysosomal hydrolase responsible for the degradation of the |
| GO:0006027 glycosaminoglycan catabolic process | IEA GO_REF:0000107 | ACCEPT | Summary: Ensembl-transferred annotation to the parent glycosaminoglycan catabolic process term. This correctly captures IDUA's role in GAG breakdown and is the immediate parent of the HS and DS catabolic annotations. Reason: IDUA is a bona fide GAG-degrading lysosomal exo-glycosidase; the term is correct, if broader than the HS/DS-specific terms. Supporting Evidence: PMID:24036510 IDUA participates in the stepwise degradation of the glycosaminoglycans (GAGs) heparan sulphate and dermatan sulphate, by removing a single Ξ±-L-iduronyl residue from the non-reducing ends of these complex polysaccharides. |
| GO:0030200 heparan sulfate proteoglycan catabolic process | TAS Reactome:R-HSA-2024096 | ACCEPT | Summary: Reactome traceable-author annotation placing IDUA in the HS-GAG degradation pathway. Concordant with the experimentally supported role in heparan sulfate catabolism. Reason: Reactome curates IDUA as a step in lysosomal heparan sulfate degradation, consistent with the enzyme's characterized activity. Supporting Evidence: Reactome:R-HSA-1678716 The lysosomal enzyme alpha-L-iduronidase (IDUA) cleaves the terminal L-iduronic acid residue from either heparan sulfate or dermatan sulfate chains of proteoglycans |
| GO:0030209 dermatan sulfate proteoglycan catabolic process | TAS Reactome:R-HSA-1793186 | ACCEPT | Summary: Reactome traceable-author annotation placing IDUA in dermatan sulfate degradation (hydrolysis of the unsulfated alpha-L-iduronosidic link in DS). Concordant with the enzyme's EC 3.2.1.76 reaction. Reason: Curated Reactome pathway step matching IDUA's defining catalytic reaction on dermatan sulfate. Supporting Evidence: Reactome:R-HSA-1793186 The lysosomal enzyme alpha-L-iduronidase (IDUA) hydrolyzes the nonreducing terminal iduronide glycosidic bond in heparan sulfate and dermatan sulfate |
| GO:0003940 L-iduronidase activity | TAS Reactome:R-HSA-1678716 | ACCEPT | Summary: Reactome traceable-author assertion of L-iduronidase activity (cleavage of terminal L-iduronate from HS chains). Core molecular function. Reason: Restates the enzyme's defining catalytic activity within a curated reaction. Supporting Evidence: Reactome:R-HSA-1678716 The lysosomal enzyme alpha-L-iduronidase (IDUA) cleaves the terminal L-iduronic acid residue from either heparan sulfate or dermatan sulfate chains of proteoglycans |
| GO:0003940 L-iduronidase activity | TAS Reactome:R-HSA-1793186 | ACCEPT | Summary: Reactome traceable-author assertion of L-iduronidase activity (hydrolysis of the unsulfated alpha-L-iduronosidic link in DS). Core molecular function. Reason: Restates the enzyme's defining catalytic activity within a curated dermatan sulfate reaction. Supporting Evidence: Reactome:R-HSA-1793186 The lysosomal enzyme alpha-L-iduronidase (IDUA) hydrolyzes the nonreducing terminal iduronide glycosidic bond in heparan sulfate and dermatan sulfate |
| GO:0003940 L-iduronidase activity | TAS Reactome:R-HSA-2090037 | ACCEPT | Summary: Reactome traceable-author assertion of L-iduronidase activity within a heparan sulfate chain hydrolysis reaction. Core molecular function. Reason: Duplicate curated assertion of the enzyme's defining catalytic activity. Supporting Evidence: Reactome:R-HSA-1678716 The lysosomal enzyme alpha-L-iduronidase (IDUA) cleaves the terminal L-iduronic acid residue from either heparan sulfate or dermatan sulfate chains of proteoglycans |
| GO:0003940 L-iduronidase activity | TAS Reactome:R-HSA-2206299 | ACCEPT | Summary: Reactome traceable-author assertion of L-iduronidase activity (associated with a defective-IDUA/disease reaction). Core molecular function. Reason: Duplicate curated assertion of the enzyme's defining catalytic activity in the MPS I disease context. Supporting Evidence: Reactome:R-HSA-1678716 The lysosomal enzyme alpha-L-iduronidase (IDUA) cleaves the terminal L-iduronic acid residue from either heparan sulfate or dermatan sulfate chains of proteoglycans |
| GO:0003940 L-iduronidase activity | TAS Reactome:R-HSA-9036037 | ACCEPT | Summary: Reactome traceable-author assertion of L-iduronidase activity within a heparan-sulfate-chain reaction. Core molecular function. Reason: Duplicate curated assertion of the enzyme's defining catalytic activity. Supporting Evidence: Reactome:R-HSA-1678716 The lysosomal enzyme alpha-L-iduronidase (IDUA) cleaves the terminal L-iduronic acid residue from either heparan sulfate or dermatan sulfate chains of proteoglycans |
| GO:0003940 L-iduronidase activity | TAS Reactome:R-HSA-9036041 | ACCEPT | Summary: Reactome traceable-author assertion of L-iduronidase activity (associated with the defective-IDUA dermatan sulfate reaction). Core molecular function. Reason: Duplicate curated assertion of the enzyme's defining catalytic activity. Supporting Evidence: Reactome:R-HSA-1793186 The lysosomal enzyme alpha-L-iduronidase (IDUA) hydrolyzes the nonreducing terminal iduronide glycosidic bond in heparan sulfate and dermatan sulfate |
| GO:0003940 L-iduronidase activity | EXP PMID:23959878 Human Ξ±-L-iduronidase uses its own N-glycan as a substrate-b... | ACCEPT | Summary: Experimental (EXP) assignment of L-iduronidase activity from a structural/kinetic study of human IDUA that determined the crystal structure with iduronate bound and characterized catalysis, including the role of the Asn372 N-glycan. Reason: Direct experimental determination of the enzyme's catalytic activity in humans; this is the strongest evidence for the core molecular function. Supporting Evidence: PMID:23959878 human Ξ±-l-iduronidase (hIDUA), of which a dysfunction causes accumulation of dermatan/heparan sulfate leading to mucopolysaccharidosis type I, uses its own N-glycan as a substrate binding and catalytic module. |
| GO:0030211 heparin proteoglycan catabolic process | IMP PMID:21873421 Mucopolysaccharidosis type I, unique structure of accumulate... | ACCEPT | Summary: IMP annotation from a murine Idua-knockout study showing accumulation of heparan sulfate with a terminal iduronate-capped disaccharide, demonstrating that Idua is required for degradation of iduronate-containing heparan sulfate/heparin chains. Reason: Loss of Idua in mice blocks removal of terminal iduronate from HS/heparin, causing pathological accumulation; strong genetic evidence for IDUA's role in catabolism of iduronate-bearing HS/heparin. Retained (heparin is closely related to HS, and the phenotype is directly demonstrated). Supporting Evidence: PMID:21873421 representing the terminal iduronic acid residue capping the non-reducing end of the HS chain, where no further degradation can occur in the absence of Idua. |
| GO:0070062 extracellular exosome | HDA PMID:23533145 In-depth proteomic analyses of exosomes isolated from expres... | KEEP AS NON CORE | Summary: High-throughput mass-spectrometry detection of IDUA among ~900 proteins in exosomes isolated from expressed prostatic secretions in urine. This reflects presence of the secretory/lysosomal protein in extracellular vesicles rather than a distinct functional site. Reason: A proteomics survey placed IDUA in urinary exosomes; lysosomal/secretory hydrolases are commonly recovered in extracellular vesicles. This is a valid detection but not the enzyme's primary functional location, so it is retained as non-core. Supporting Evidence: PMID:23533145 In pooled EPS-urine exosome samples, ~900 proteins were detected. |
| GO:0003940 L-iduronidase activity | IDA PMID:24036510 Insights into mucopolysaccharidosis I from the structure and... | ACCEPT | Summary: Direct assay (IDA) of L-iduronidase activity from the human IDUA crystal-structure and enzymology study that captured Michaelis and glycosyl-enzyme intermediate complexes with iduronate analogs and defined the retaining double-displacement mechanism. Reason: Definitive experimental characterization of the enzyme's catalytic activity and mechanism; the primary evidence for the core molecular function. Supporting Evidence: PMID:24036510 IDUA is an Ξ±-retaining glycoside hydrolase with strict substrate specificity for L-IdoA |
| GO:0030209 dermatan sulfate proteoglycan catabolic process | IDA PMID:24036510 Insights into mucopolysaccharidosis I from the structure and... | ACCEPT | Summary: IDA annotation of dermatan sulfate proteoglycan catabolism from the structural and enzymological study showing IDUA removes alpha-L-iduronate from the non-reducing ends of dermatan sulfate (and heparan sulfate). Reason: Experimentally grounded in IDUA's demonstrated action on dermatan sulfate; a core biological process. Supporting Evidence: PMID:24036510 IDUA participates in the stepwise degradation of the glycosaminoglycans (GAGs) heparan sulphate and dermatan sulphate, by removing a single Ξ±-L-iduronyl residue from the non-reducing ends of these complex polysaccharides. |
| GO:0043202 lysosomal lumen | TAS Reactome:R-HSA-2206299 | ACCEPT | Summary: Reactome traceable-author localization of IDUA to the lysosomal lumen (disease reaction context). Correct core compartment. Reason: Consistent with IDUA being a soluble lysosomal-lumen hydrolase. Supporting Evidence: Reactome:R-HSA-1678716 The lysosomal enzyme alpha-L-iduronidase (IDUA) |
| GO:0043202 lysosomal lumen | TAS Reactome:R-HSA-9036037 | ACCEPT | Summary: Reactome traceable-author localization of IDUA to the lysosomal lumen (heparan sulfate reaction context). Correct core compartment. Reason: Consistent with IDUA being a soluble lysosomal-lumen hydrolase. Supporting Evidence: Reactome:R-HSA-1678716 The lysosomal enzyme alpha-L-iduronidase (IDUA) |
| GO:0043202 lysosomal lumen | TAS Reactome:R-HSA-9036041 | ACCEPT | Summary: Reactome traceable-author localization of IDUA to the lysosomal lumen (dermatan sulfate reaction context). Correct core compartment. Reason: Consistent with IDUA being a soluble lysosomal-lumen hydrolase. Supporting Evidence: Reactome:R-HSA-1793186 The lysosomal enzyme alpha-L-iduronidase (IDUA) |
| GO:0043202 lysosomal lumen | TAS Reactome:R-HSA-1678716 | ACCEPT | Summary: Reactome traceable-author localization of IDUA to the lysosomal lumen (HS chain cleavage reaction). Correct core compartment. Reason: Consistent with IDUA being a soluble lysosomal-lumen hydrolase. Supporting Evidence: Reactome:R-HSA-1678716 The lysosomal enzyme alpha-L-iduronidase (IDUA) |
| GO:0043202 lysosomal lumen | TAS Reactome:R-HSA-1793186 | ACCEPT | Summary: Reactome traceable-author localization of IDUA to the lysosomal lumen (DS link hydrolysis reaction). Correct core compartment. Reason: Consistent with IDUA being a soluble lysosomal-lumen hydrolase. Supporting Evidence: Reactome:R-HSA-1793186 The lysosomal enzyme alpha-L-iduronidase (IDUA) |
| GO:0043202 lysosomal lumen | TAS Reactome:R-HSA-2090037 | ACCEPT | Summary: Reactome traceable-author localization of IDUA to the lysosomal lumen (heparan sulfate chain reaction). Correct core compartment. Reason: Consistent with IDUA being a soluble lysosomal-lumen hydrolase. Supporting Evidence: Reactome:R-HSA-1678716 The lysosomal enzyme alpha-L-iduronidase (IDUA) |
| GO:0003940 L-iduronidase activity | TAS PMID:2470345 Immunopurification and characterization of human alpha-L-idu... | ACCEPT | Summary: Traceable-author annotation of L-iduronidase activity from the immunopurification and biochemical characterization of the human liver enzyme, which measured its activity toward heparan sulfate- and dermatan sulfate-derived substrates. Reason: An early experimental characterization establishing the enzyme's catalytic activity on GAG-derived substrates; core molecular function. Supporting Evidence: PMID:2470345 activities towards disaccharide substrates derived from two glycosaminoglycan sources, heparan sulphate and dermatan sulphate. |
| GO:0005984 disaccharide metabolic process | TAS PMID:2470345 Immunopurification and characterization of human alpha-L-idu... | MARK AS OVER ANNOTATED | Summary: Traceable-author annotation of disaccharide metabolic process, derived from an in vitro assay in which the two enzyme forms were tested against GAG-derived disaccharide substrates. IDUA's physiological substrates are polymeric heparan sulfate and dermatan sulfate, not free disaccharides. Reason: The disaccharide substrates were an experimental convenience for measuring activity; the in vivo role is exolytic removal of terminal iduronate from GAG polymers, captured by the glycosaminoglycan/HS/DS catabolic terms. This general metabolic-process term overstates a biological role in disaccharide metabolism. Supporting Evidence: PMID:2470345 activities towards disaccharide substrates derived from two glycosaminoglycan sources, heparan sulphate and dermatan sulphate. PMID:24036510 by removing a single Ξ±-L-iduronyl residue from the non-reducing ends of these complex polysaccharides. |
Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)Loading supporting contentβ¦
Download this section (compressed HTML)